¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"European foreign affairs review."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • scalp foreign body
    ¸Ó¸®µ¤°³³»À̹°, µÎÇdz»À̹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • foreign-body granuloma
    À̹°À°¾ÆÁ¾
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • foreign body
    À̹°
  • foreign body
    À̹°Áú
  • foreign body
    À̹°(ì¶Úª)
  • foreign body appendicitis
    À̹°¼º Ãæ¼ö¿°.
  • foreign body forceps
    À̹°°âÀÚ(¡­°âÀÚ).
  • foreign body forceps
    À̹°Áý°Ô
  • foreign body giant cell
    À̹°°Å¼¼Æ÷.
  • foreign body giant cell
    À̹°°Å¼¼Æ÷.(¡­ËÝá¬øà)
  • foreign body granuloma
    À̹°À°¾ÆÁ¾
  • foreign body granuloma
    À̹°¼ºÀ°¾ÆÁ¾(¡­ë¿ä´ðþ)
  • foreign body in air passage
    ±âµµ³»À̹°.
  • foreign body in the esophagus
    ½ÄµµÀ̹°
  • foreign body in the larynx
    ÈĵÎÀ̹°
  • foreign body in the nose
    ºñ°­À̹°
  • foreign body in the pharynx
    ÀεÎÀ̹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MEDPAR Medical Provider Analysis and Review; Medicare Provider Analysis and Review
PRC packed red cells; peer review committee; phase response curve; plasma renin concentration; professio...
CFMA Council for Medical Affairs
DMA department of medical assistance; dimethylamine; dimethylaniline; dimethylarginine; direct memory ac...
NAVAPAM National Association of Veterans Affairs Physicians and Ambulatory Care Managers
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECFMG Educational Commission for Foreign Medical Graduates
FBGC Foreign Body Giant Cell
FMG Foreign Medical Graduate
FBs Foreign bodies
FB Foreign body
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • metallic foreign body
    ±Ý¼Ó¼º À̹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
review literature Published material which provides an examination of recent or current literature. Reviews can cover a wide range of subject matter of various levels of completeness or comprehensiveness based on analyses of publications on the subject. The review may reflect the state of the art. It also includes reviews as a literary form. The presence of research findings or case reports does not preclude designation as a review.
(12 Dec 1998)
review, multicase A type of review literature giving demographic, laboratory, and clinical data on a group of persons or animals ranging from most of the known cases of a rare condition in large populations on whom the results of research will lead to the establishing of epidemiological analyses or predictions of the occurrence and natural history of diseases. It is differentiated from review of reported cases in that the latter generally reports a single case as a supplement to a presentation, however brief and limited, of other cases known to have been reported.
(12 Dec 1998)
review of reported cases Literature reporting - to the best of the author's ability - all known cases of a disease. The study is usually generated by the investigator's encounter with patients with a given disease and includes the investigator's own cases. The range of time will encompass historical cases and recent cases. The review usually cites the literature in which the known cases were published and may or may not include clinical and laboratory data.
(12 Dec 1998)
review, tutorial A type of review citing literature that will give the user a general and reasonably thorough coverage of a subject with which he may or may not be familiar. It often substitutes as a refresher course for a physician to update his or her awareness or as a crash course for a student unfamiliar with the subject.
(12 Dec 1998)
physician payment review commission A commission created by the consolidated omnibus reconciliation act of 1985, enacted in 1986, and given the mandate to advise congress on medicare-physician payment. The commission members are appointed by the u.s. Office of technology assessment.
(12 Dec 1998)
concurrent review Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.
(12 Dec 1998)
professional review organizations Organizations representing designated geographic areas which have contracts under the pro program to review the medical necessity, appropriateness, quality, and cost-effectiveness of care received by medicare beneficiaries. Peer review improvement act, pl 97-248, 1982.
(12 Dec 1998)
scientific integrity review Designation for reports by the united states office of research integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the nih guide for grants and contracts.
(12 Dec 1998)
drug utilization review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993.
(12 Dec 1998)
insurance claim review Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.
(12 Dec 1998)
utilization review An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.
(12 Dec 1998)
giant cells, foreign-body Multinucleated cells (fused macrophages), characteristic of granulomatous inflammation, which form around exogenous material in the skin. They are similar in appearance to langhans giant cells (giant cells, langhans), but foreign-body giant cells have more abundant chromatin and their nuclei are scattered in an irregular pattern in the cytoplasm.
(12 Dec 1998)
granuloma, foreign-body Histiocytic, inflammatory response to a foreign body. It consists of modified macrophages with multinucleated giant cells, in this case foreign-body giant cells (giant cells, foreign-b0dy), usually surrounded by lymphocytes.
(12 Dec 1998)
foreign 1. Outside; extraneous; separated; alien; as, a foreign country; a foreign government. "Foreign worlds."
2. Not native or belonging to a certain country; born in or belonging to another country, nation, sovereignty, or locality; as, a foreign language; foreign fruits. "Domestic and foreign writers." "Hail, foreign wonder! Whom certain these rough shades did never breed." (Milton)
3. Remote; distant; strange; not belonging; not connected; not pertaining or pertient; not appropriate; not harmonious; not agreeable; not congenial; with to or from; as, foreign to the purpose; foreign to one's nature. "This design is not foreign from some people's thoughts." (Swift)
4. Held at a distance; excluded; exiled. "Kept him a foreign man still; which so grieved him, That he ran mad and died." (Shak) Foreign attachment, a substance occurring in any part of the body where it does not belong, and usually introduced from without. Foreign office, that department of the government of Great Britain which has charge British interests in foreign countries.
Synonym: Outlandish, alien, exotic, remote, distant, extraneous, extrinsic.
Origin: OE. Forein, F. Forain, LL. Foraneus, fr. L. Foras, foris, out of doors, abroad, without; akin to fores doors, and E. Door. See Door, and cf. Foreclose, Forfeit, Forest, Forum.
Source: Websters Dictionary
(01 Mar 1998)
foreign body Anything in the tissues or cavities of the body that has been introduced there from without, and that is not rapidly absorbable.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • European Recovery Program
    ¹Ì±¹ ±¹¹«Àå°ü MarshallÁ¦¾ÈÀÇ À¯·´ ºÎÈï °èȹ
  • European plan
    À¯·´½Ä(È£ÅÚ¿¡¼­ ¹æ°ª°ú ½Ä»ç ´ë±ÝÀ» µû·Î °ì»êÇÏ´Â °Í)
  • anti European
    ¼­À¯·´ÀÇ (»çȸ,°æÁ¦,¹®È­Àû) ÅëÇÕ ¹Ý´ëÀÇ;¿µ±¹ÀÇ EC°¡¸Í ¹Ý´ëÀÇ
  • european
    À¯·´ÀÇ;À¯·´»ç¶÷(ÀÇ)
  • european common market
    À¯·´°øµ¿½ÃÀå
  • european community
    À¯·´°øµ¿Ã¼
  • european defense community
    À¯·´¹æÀ§°øµ¿Ã¼
  • european economic community
    À¯·´°æÁ¦°øµ¿Ã¼
  • european free trade association
    À¯·´ÀÚÀ¯¹«¿ª¿¬ÇÕ
  • european political community
    À¯·´Á¤Ä¡°øµ¿Ã¼
  • foreign
    ¿Ü±¹ÀÇ,´Ù¸¥
  • Foreign Minister
    (¿µ,¹Ì ÀÌ¿ÜÀÇ) ¿Ü¹«ºÎ Àå°ü )
  • Foreign Office
    ¿Ü¹«ºÎ
  • Foreign Relations Committee
    »ó¿ø ¿Ü±³ À§¿øÈ¸
  • Foreign Secretary
    (1969³â±îÁöÀÇ) ¿Ü¹«ºÎ Àå°ü )
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á